DHHS, National Institute on Drug Abuse, Contracts Management Branch, OPRM, Parklawn Building, Room 10-49, 5600 Fishers Lane, Rockville, Maryland 20857

A -- GMP SYNTHESIS OF BULK DRUG SUBSTANCES SOL NO1DA-6-8069 DUE 061496 POC Point of Contact, Kenneth E. Goodling, Contracting Officer, Phone: (301) 443-6677 The National Institute on Drug Abuse (NIDA) is soliciting proposals under a 100% Small Business Set-Aside (SIC 2833 - 750 employees) from qualified small businesses having the capability to manufacture bulk drug substances under Good Manufacturing Practices (GMP), using the regulations and guidelines listed in the Code of Federal Regulations, Food and Drugs, 21, Part 211, ''Current Good Manufacturing Practice for Finished Pharmaceuticlas''. These bulk drugs will be used to support NIDA clinical trials. It is estimated that a three year contract, with two one-year options, will result from this procurement. Estimated issuance date of RFP No. N01DA-6-8069 is May 1, 1996 and responses are due to be received in the Contracting Office 45 calendar days thereafter. Written requests for copies of the solicitation will be honored if received within thirty calendar days after issuance of the solicitation. Written requests received after this period will be filled on a first-come, first-served basis until the supply is exhausted; however, there is no assurance that copies requested after the thirieth day will reach the requestor before the due date for receipt of responses. Written requests shall be forwarded to the attention of the Contracting Officer. See Note 1. (0108)

Loren Data Corp. http://www.ld.com (SYN# 0005 19960418\A-0005.SOL)